MESODERMALE KILLERZELLE (MK)

European patent · EP3911733 · In force

Register entry

Publication number
EP3911733
Application number
EP20700533
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 13, 2020
Published
Nov 24, 2021
Granted
Aug 21, 2024
Protection ends at the latest
Jan 12, 2040
Next annual fee due
Jan 31, 2027
IPC classes
C12N 5/077 (2010.01)
C12N 5/0783 (2010.01)
A61K 35/17 (2015.01)
A61P 35/00 (2006.01)
Priority
GB 201900554 15.01.2019
GB 201916842 19.11.2019
PCT application
PCT/GB2020/050060 13.01.2020
PCT publication
WO2020/148520 23.07.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Jul 2, 2025

    Change

    Published in Swissreg on 02.07.2025

  3. Mar 26, 2025

    Change

    Published in Swissreg on 26.03.2025

  4. Feb 20, 2025

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 20.02.2025

  5. Aug 21, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.08.2024

Parties

Holder

Cell Therapy Limited

Celixir House Stratford-Upon-Avon Business & Tehnology Park Innovation Way, Stratford-Upon-Avon, Warwickshire CV37 7GZ, GB

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventor

CHAPMAN, Lee

Stratford-Upon- Avon Warwickshire CV37 7GZ, GB

SULTAN, Sabena

Stratford-Upon- Avon Warwickshire CV37 7GZ, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.